SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-028388
Filing Date
2009-07-31
Accepted
2009-07-31 16:22:47
Documents
36
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c88525e10vq.htm 10-Q 592199
2 EXHIBIT 31.1 c88525exv31w1.htm EX-31.1 5864
3 EXHIBIT 31.2 c88525exv31w2.htm EX-31.2 5900
4 EXHIBIT 32.1 c88525exv32w1.htm EX-32.1 2239
5 EXHIBIT 32.2 c88525exv32w2.htm EX-32.2 2290
  Complete submission text file 0000950123-09-028388.txt   2510495

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20090630.xml EX-101.INS 439233
7 EX-101 SCHEMA DOCUMENT celg-20090630.xsd EX-101.SCH 20638
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20090630_cal.xml EX-101.CAL 50686
9 EX-101 LABELS LINKBASE DOCUMENT celg-20090630_lab.xml EX-101.LAB 213847
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20090630_pre.xml EX-101.PRE 129254
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20090630_def.xml EX-101.DEF 34271
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: 10-Q | Act: 34 | File No.: 000-16132 | Film No.: 09977623
SIC: 2834 Pharmaceutical Preparations